866-997-4948 (US-Canada Toll Free)

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs...

Show More

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

Show Less
  • Pneumocystis Infection - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    29 Pages

    Pneumocystis Infection - Pipeline Review, H2 2014 Summary Global Markets Directs, Pneumocystis Infection - Pipeline Review, H2 2014, provides an overview of the Pneumocystis Infections therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pneumocystis Infection, complete with comparative analysis at various stages, therapeutics assessment by...

    USD 2000View Report
  • Oligodendroglioma - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    90 Pages

    Oligodendroglioma - Pipeline Review, H2 2014 Summary Global Markets Directs, Oligodendroglioma - Pipeline Review, H2 2014, provides an overview of the Oligodendrogliomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Oligodendroglioma, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report
  • Hepatic (Liver) Tumor - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    31 Pages

    Hepatic (Liver) Tumor - Pipeline Review, H2 2014 Summary Global Markets Directs, Hepatic (Liver) Tumor - Pipeline Review, H2 2014, provides an overview of the Hepatic (Liver) Tumors therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatic (Liver) Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug...

    USD 2000View Report
  • Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    51 Pages

    Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014 Summary Global Markets Directs, Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014, provides an overview of the Metastatic Transitional Cell Cancer (Urothelial Cell Cancer)s therapeutic pipeline. This report provides comprehensive information on the therapeutic...

    USD 2000View Report
  • Age Related Functional Decline - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    27 Pages

    Age Related Functional Decline - Pipeline Review, H2 2014 Summary Global Markets Directs, Age Related Functional Decline - Pipeline Review, H2 2014, provides an overview of the Age Related Functional Declines therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Age Related Functional Decline, complete with comparative analysis at various...

    USD 2000View Report
  • Ageing - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    50 Pages

    Ageing - Pipeline Review, H2 2014 Summary Global Markets Directs, Ageing - Pipeline Review, H2 2014, provides an overview of the Ageings therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ageing, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...

    USD 2000View Report
  • Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    60 Pages

    Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014 Summary Global Markets Directs, Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014, provides an overview of the Resistant Pseudomonas Aeruginosa Infectionss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Resistant Pseudomonas Aeruginosa...

    USD 2000View Report
  • Gastroenteritis - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    51 Pages

    Gastroenteritis - Pipeline Review, H2 2014 Summary Global Markets Directs, Gastroenteritis - Pipeline Review, H2 2014, provides an overview of the Gastroenteritiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gastroenteritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of...

    USD 2000View Report
  • Mild Psoriasis - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    46 Pages

    Mild Psoriasis - Pipeline Review, H2 2014 Summary Global Markets Directs, Mild Psoriasis - Pipeline Review, H2 2014, provides an overview of the Mild Psoriasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mild Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...

    USD 2000View Report
  • Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    38 Pages

    Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014 Summary Global Markets Directs, Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014, provides an overview of the Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infectionss therapeutic pipeline. This report...

    USD 2000View Report
  • Oropharyngeal Cancer - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    75 Pages

    Oropharyngeal Cancer - Pipeline Review, H2 2014 Summary Global Markets Directs, Oropharyngeal Cancer - Pipeline Review, H2 2014, provides an overview of the Oropharyngeal Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Oropharyngeal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug...

    USD 2000View Report
  • Lennox-Gastaut Syndrome - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    49 Pages

    Lennox-Gastaut Syndrome - Pipeline Review, H2 2014 Summary Global Markets Directs, Lennox-Gastaut Syndrome - Pipeline Review, H2 2014, provides an overview of the Lennox-Gastaut Syndromes therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Lennox-Gastaut Syndrome, complete with comparative analysis at various stages, therapeutics assessment...

    USD 2000View Report
  • Cholestasis - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    38 Pages

    Cholestasis - Pipeline Review, H2 2014 Summary Global Markets Directs, Cholestasis - Pipeline Review, H2 2014, provides an overview of the Cholestasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cholestasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...

    USD 2000View Report
  • Familial Chylomicronemia (Type I Hyperlipoproteinemia) - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    59 Pages

    Familial Chylomicronemia (Type I Hyperlipoproteinemia) - Pipeline Review, H2 2014 Summary Global Markets Directs, Familial Chylomicronemia (Type I Hyperlipoproteinemia) - Pipeline Review, H2 2014, provides an overview of the Familial Chylomicronemia (Type I Hyperlipoproteinemia)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Familial...

    USD 2000View Report
  • Muscle Spasm - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    35 Pages

    Muscle Spasm - Pipeline Review, H2 2014 Summary Global Markets Directs, Muscle Spasm - Pipeline Review, H2 2014, provides an overview of the Muscle Spasms therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Muscle Spasm, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...

    USD 2000View Report
  • Pheochromocytoma - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    64 Pages

    Pheochromocytoma - Pipeline Review, H2 2014 Summary Global Markets Directs, Pheochromocytoma - Pipeline Review, H2 2014, provides an overview of the Pheochromocytomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pheochromocytoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism...

    USD 2000View Report
  • Pancreatic Endocrine Tumor - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    61 Pages

    Pancreatic Endocrine Tumor - Pipeline Review, H2 2014 Summary Global Markets Directs, Pancreatic Endocrine Tumor - Pipeline Review, H2 2014, provides an overview of the Pancreatic Endocrine Tumors therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pancreatic Endocrine Tumor, complete with comparative analysis at various stages,...

    USD 2000View Report
  • Ureter Cancer - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    65 Pages

    Ureter Cancer - Pipeline Review, H2 2014 Summary Global Markets Directs, Ureter Cancer - Pipeline Review, H2 2014, provides an overview of the Ureter Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ureter Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...

    USD 2000View Report
  • Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    89 Pages

    Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2014 Summary Global Markets Directs, Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2014, provides an overview of the Complicated Skin And Skin Structure Infections (cSSSI)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for...

    USD 2000View Report
  • Sjogren's Syndrome - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    55 Pages

    Sjogren's Syndrome - Pipeline Review, H2 2014 Summary Global Markets Directs, Sjogren's Syndrome - Pipeline Review, H2 2014, provides an overview of the Sjogren's Syndromes therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sjogren's Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report
  • Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    45 Pages

    Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014 Summary Global Markets Directs, Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014, provides an overview of the Burkholderia Pseudomallei Infectionss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Burkholderia Pseudomallei Infections, complete with comparative...

    USD 2000View Report
  • Cryptosporidiosis - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    32 Pages

    Cryptosporidiosis - Pipeline Review, H2 2014 Summary Global Markets Directs, Cryptosporidiosis - Pipeline Review, H2 2014, provides an overview of the Cryptosporidiosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cryptosporidiosis, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report
  • Posterior Uveitis - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    55 Pages

    Posterior Uveitis - Pipeline Review, H2 2014 Summary Global Markets Directs, Posterior Uveitis - Pipeline Review, H2 2014, provides an overview of the Posterior Uveitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Posterior Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report
  • Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    35 Pages

    Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline Review, H2 2014 Summary Global Markets Directs, Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline Review, H2 2014, provides an overview of the Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development...

    USD 2000View Report
  • Osteopenia - Pipeline Review, H2 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    36 Pages

    Osteopenia - Pipeline Review, H2 2014 Summary Global Markets Directs, Osteopenia - Pipeline Review, H2 2014, provides an overview of the Osteopenias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Osteopenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...

    USD 2000View Report